UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MT1-MMP regulates urothelial cell invasion via transcriptional regulation of Dickkopf-3

British journal of cancer, 2008-08, Vol.99 (4), p.663-669

2008

Volltextzugriff (PDF)

The genomic evolution of human prostate cancer

British journal of cancer, 2015-07, Vol.113 (2), p.193-198

2015

Volltextzugriff (PDF)

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening

British journal of cancer, 2011-05, Vol.104 (10), p.1656-1663

2011

Volltextzugriff (PDF)

Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress

British journal of cancer, 2013-08, Vol.109 (4), p.983-993

2013

Volltextzugriff (PDF)

Identification of pathologically insignificant prostate cancer is not accurate in unscreened men

British journal of cancer, 2014-05, Vol.110 (10), p.2405-2411

2014

Volltextzugriff (PDF)

Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result

British journal of cancer, 2010-04, Vol.102 (9), p.1335-1340

2010

Volltextzugriff (PDF)

Nuclear LYRIC AEG-1 interacts with PLZF and relieves PLZF-mediated repression

Oncogene, 2009-10, Vol.28 (41), p.3663-3670

2009

Volltextzugriff (PDF)

Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)

British journal of cancer, 2014-06, Vol.110 (12), p.2829-2836

2014

Volltextzugriff (PDF)

Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer

British journal of cancer, 2001-12, Vol.85 (12), p.1928-1936

2001

Volltextzugriff (PDF)

Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening

British journal of cancer, 2009-04, Vol.100 (7), p.1198-1204

2009

Volltextzugriff (PDF)

MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion

Oncogene, 2003-03, Vol.22 (9), p.1381-1389

2003

Volltextzugriff (PDF)

N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype

Oncogene, 2014-11, Vol.33 (45), p.5274-5287

2014

Volltextzugriff (PDF)

Robotic-assisted laparoscopic prostatectomy

British journal of cancer, 2009-11, Vol.101 (9), p.1491-1496

2009

Volltextzugriff (PDF)

International multicentre study examining selection criteria for active surveillance in men undergoing radical prostatectomy

British journal of cancer, 2012-10, Vol.107 (9), p.1467-1473

2012

Volltextzugriff (PDF)

Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma

British journal of cancer, 2006-02, Vol.94 (4), p.569-577

2006

Volltextzugriff (PDF)

An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer

British journal of cancer, 2003-03, Vol.88 (6), p.822-827

2003

Volltextzugriff (PDF)

Diagnosis of bladder cancer by immunocytochemical detection of minichromosome maintenance protein-2 in cells retrieved from urine

British journal of cancer, 2012-10, Vol.107 (8), p.1384-1391

2012

Volltextzugriff (PDF)

Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study

British journal of cancer, 2011-03, Vol.104 (5), p.875-881

2011

Volltextzugriff (PDF)

Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype

Oncogene, 2014-12, Vol.33 (50), p.5666-5674

2014

Volltextzugriff (PDF)

Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer

British journal of cancer, 2007-05, Vol.96 (9), p.1384-1393

2007

Volltextzugriff (PDF)

Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study

British journal of cancer, 2011-09, Vol.105 (7), p.931-937

2011

Volltextzugriff (PDF)

RAS pathways in prostate cancer - mediators of hormone resistance?

Current cancer drug targets, 2010-12, Vol.10 (8), p.834-839

2010

Volltextzugriff (PDF)

Latest results from the UK trials evaluating prostate cancer screening and treatment: The CAP and ProtecT studies

European journal of cancer (1990), 2010-11, Vol.46 (17), p.3095-3101

2010

Volltextzugriff (PDF)

Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes

Annals of oncology, 2015-04, Vol.26 (4), p.756-761

2015

Volltextzugriff (PDF)

Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men

British journal of cancer, 2003-06, Vol.88 (11), p.1682-1686

2003

Volltextzugriff (PDF)

1 – 25 von 407

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(391)
Mit Volltextzugriff
(367)

Publikationsform

Sprache

Englisch
(405)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

MT1-MMP regulates urothelial cell invasion via transcriptional regulation of Dickkopf-3

The genomic evolution of human prostate cancer

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening

Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress

Identification of pathologically insignificant prostate cancer is not accurate in unscreened men

Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result

Nuclear LYRIC AEG-1 interacts with PLZF and relieves PLZF-mediated repression

Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)

Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer

Mean sojourn time, overdiagnosis, and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening

MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion

N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype

Robotic-assisted laparoscopic prostatectomy

International multicentre study examining selection criteria for active surveillance in men undergoing radical prostatectomy

Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma

An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer

Diagnosis of bladder cancer by immunocytochemical detection of minichromosome maintenance protein-2 in cells retrieved from urine

Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study

Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype

Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer

Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study

RAS pathways in prostate cancer - mediators of hormone resistance?

Latest results from the UK trials evaluating prostate cancer screening and treatment: The CAP and ProtecT studies

Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes

Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men

Aktive Filter

Suchergebnisse filtern